Novartis Oncology Universal Co-pay Program

Manufacturer copay assistance · Sandostatin (J2354) · Novartis

$10-$25 per 30-day… · Maximum benefit $30,000 per calendar year · Covers drug cost only — administration billed separately

Program terms

Published terms from the manufacturer. Per-patient eligibility is confirmed at enrollment.

Assistance type

Copay Assist

Patient pays

$10-$25 per 30-day supply (varies by brand)

Maximum benefit

$30,000 per calendar year

What it covers

Covers drug cost only — administration billed separately

Insurance

commercial no medicare no medicaid no government

Short-acting octreotide — same Novartis programs as LAR

Medicare or Medicaid patient?

This manufacturer program excludes government insurance. Foundation disease funds are the route instead — status shown as of each fund's last verification.

No foundation fund in our catalog currently matches Sandostatin — check the full fund board.

What will the patient owe before assistance?

Run a benefits estimate for Sandostatin — the program's cap applies against the patient share CareCost calculates.

Estimate Sandostatin →

Common questions

Does Sandostatin have a copay card?

Yes — Novartis Oncology Universal Co-pay Program from Novartis. $10-$25 per 30-day supply (varies by brand). Commercial insurance is required; Medicare and Medicaid patients are not eligible.

How much does Sandostatin cost with the copay card?

$10-$25 per 30-day supply (varies by brand) Maximum benefit: $30,000 per calendar year. Covers drug cost only — administration billed separately

Who is eligible for Novartis Oncology Universal Co-pay Program?

Accepted insurance: commercial. Not eligible: medicare, medicaid, government.